American Hip Institute, Chicago, Illinois, U.S.A.; American Hip Institute Research Foundation, Chicago, Illinois, U.S.A.; AMITA Health St. Alexius Medical Center, Hoffman Estates, Illinois, U.S.A..
American Hip Institute Research Foundation, Chicago, Illinois, U.S.A.
Arthroscopy. 2021 Apr;37(4):1353-1356. doi: 10.1016/j.arthro.2021.01.057. Epub 2021 Feb 10.
Much focus in research has been given to minimizing type I errors, where we incorrectly conclude that there is a difference between 2 treatments or populations. In contrast, our standard scientific method and power analysis allows for a much greater rate of type II errors, in which we fail to show a difference when, in fact, one exists (≥20% rate of type II errors vs ≤5% rate of type I errors). Additional factors that can cause type II errors may propel their prevalence to well in excess of 20%. Failure to reject the null hypothesis may be a tolerable outcome in a certain proportion of studies. However, type II errors may become dangerous when the conclusions of a study overreach, incorrectly stating that there is no difference, when, in fact, a difference exists. Type II errors resulting in overreaching conclusions may impede incremental advances in our field, as the advantages of small improvements may go undetected. To avert this danger in studies that fail to meet statistical significance, we as researchers (20% or more, vs 5% for type I errors) be precise in our conclusions stating simply that the null hypothesis could not be rejected.
研究的重点主要放在最小化 I 类错误上,即我们错误地得出两种治疗方法或两种人群之间存在差异的结论。相比之下,我们的标准科学方法和功效分析允许更大的 II 类错误率,即当实际上存在差异时,我们未能显示出差异(II 类错误率≥20%,I 类错误率≤5%)。可能导致 II 类错误的其他因素可能会导致其发生率远远超过 20%。在一定比例的研究中,不能拒绝零假设可能是可以接受的结果。然而,当研究的结论超出范围,错误地表明不存在差异,而实际上存在差异时,II 类错误可能会变得危险。导致过度结论的 II 类错误可能会阻碍我们领域的渐进式进展,因为小的改进的优势可能未被发现。为了避免在未达到统计学意义的研究中出现这种危险,作为研究人员(20%或更多,I 类错误为 5%),我们应该在结论中准确地指出,无法拒绝零假设。